Ranchi: Packed in 14 temperature-controlled boxes, 16,186 vials of the Covishield vaccine manufactured by Pune-based Serum Institute of India (SII) arrived in a commercial flight of Spicejet from Mumbai around 9am on Wednesday at Ranchi’s Birsa Munda International Airport.
The vaccines, received by the state government’s department of health, medical education and family welfare, will be used to inoculate 1.31 lakh health workers of the state and nearly 35,000 Indian Army personnel, stationed in Ranchi military station and Ramgarh’s Punjab Regimental Centre.
After the aircraft landed, the boxes, containing 1,200 vials each, were loaded on a vaccination van of the state health mission and brought to the department’s warehouse at RCH campus in Namkum, 13 kilometre from the airport.
India readies for COVID-19 vaccination but vexed questions on the solution remain downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
th G20 Summit taking place on a virtual platform in November 2020 bears testimony to the unprecedented challenges brought about by the COVID-19 pandemic, both in terms of changing geopolitical chess board and the corresponding economic downturn. In the prevailing circumstances, many G20 members and the world at large are looking towards India as a compelling, credible, and trustworthy major power playing strategic role in the post COVID-19 global recovery.
Currently, India is well-positioned to take center stage in providing robust leadership and direction in the decision-making process of the G20 grouping, so that stability and equilibrium may be restored in the emerging global order in the aftermath of COVID-19 geostrategic turmoil. India’s ambitious multi-pronged strategy and potential to play a larger strategic role is increasingly being realised by the G20 members. The argument here is that India’s capability in managing global politico-economic challenges by enhancing
Union Minister for Health and Family Welfare Harsh Vardhan. | Harsh Vardhan/Twitter
Union Health Minister Harsh Vardhan on Thursday said that some individuals may have side effects after they are administered the coronavirus vaccine, as the country gears up to undertake the mammoth task of inoculating its citizens from January 16. This includes mild fever, pain at injection site and bodyache, he said.
The minister, however, assured that there was nothing out of ordinary about it as the effects would be temporary and similar to the ones experienced while getting other vaccines.
“After being administered Covid-19 vaccine, some individuals may have side effects like mild fever, pain at injection site and bodyache,” he wrote on Twitter. “This is similar to the side effects that occur post some other vaccines. These are expected to go away on their own after some time.”
The govt has said that vaccine recipients, for now, will not have the option to choose from the two vaccines Oxford vaccine, Covishield, and indigenously developed Covaxin that have been approved for restricted emergency use in India